The effects of respiratory functions on disease activity, functionality, spinal mobility and quality of life in patients with ankylosing spondylitis

Büyükavcı, Raikan; OZKARAFAKİLİ, Mufide Arzu; Sağ, Sinem; KURAN, KADRİYE BANU

The effects of respiratory functions on disease activity, functionality, spinal mobility and quality of life in patients with ankylosing spondylitis

Raikan BÜYÜKAVCI, (İnönü Üniversitesi Turgut Özal tıp Merkezi Fiziksel Tıp ve Rehabilitasyon Anabilimdalı, Malatya, Turkey)

Sinem SAĞ, (Sakarya Eğitim ve Araştırma Hastanesi Romatoloji Bilimdalı, Sakarya, Turkey)

Mufide Arzu OZKARAFAKİLİ, (Şişli Hamidiye Etfal Eğitim ve Araştırma Hastanesi Göğüs Hastalıkları Kliniği, İstanbul, Turkey)

KADRİYE BANU KURAN (Şişli Hamidiye Etfal Eğitim ve Araştırma Hastanesi Fiziksel Tıp ve Rehabilitasyon Kliniği, İstanbul, Turkey)

Medicine Science

3 1

Yıl: 2017 Cilt: 6 Sayı: 1 Sayfa Aralığı: 69 - 72 Metin Dili: İngilizce İndeks Tarihi: 29-07-2022

The effects of respiratory functions on disease activity, functionality, spinal mobility and quality of life in patients with ankylosing spondylitis

Öz:

We aimed to determine the relationship between the pulmonary functions with disease activity, functionality, spinal mobility and quality of life in patients with ankylosing spondyilitis (AS). PATIENTS AND METHOD: 52 patients (44 male, 8 female) who were diagnosed as AS in Şişli Etfal Education and Research Hospital physical medicine and rehabilitation policlinics according to the Modified New York criteria, participated in our study. The demographic characteristics and smoking habbits were questioned, the chest expansion was measured. The functional activity, disease activity, spinal mobility measurement were evaluated by BASFI, BASDAI,BASMI (Bath Ankylosing Spondylitis functional, disease activity, metrology ındex),and the life quality was evaluated by life quality spesific to the disease (ASQOL). The respiratory functions were measured by spirometry. 52 patients in 31 patients restrictive, and in 1 patient mixed pattern pulmonary involvement were detected. There was no determined no significant difference between who detected and not detected restrictive lung disease regarding age, gender, body mass index, lung expansion (LE), history of smoking (p>0.005). Pulmonary function tests results and LE of smoker and no smoker patients were similar. While LE was found to be positively correlated with FEV1 and FVC (p<0.01); there was negative correlation between BASFI and BASMI (p<0.01). But significant relationship was not determined LE and BASDAI (p>0.05). FEV1 and FVC values were negative correlation with LE, BASFI and BASMI (p<0.05). There was no significant correlation between BASDAI and FEV1, FVC values (p<0.01) ). There were no statistically significant relationship between ASQOL and the pulmonary function tests. (p>0.05) As pulmonary involvement in AS patients was detected, we have found its effects on disease activity, patients functionality and spinal mobility in the results of our study. But as expected there was no significant relationship between pulmonary function tests and life quality

Anahtar Kelime:

Konular: Genel ve Dahili Tıp

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık

1. Diagnosis and treatment of rheumatic diseases. Göksoy T , editor. Yüce Yayım; 2001. p. 622-43.
2. Kabasakal Y. Ankylosing spondylitis. In: Gümüşdiş G, Doğanavşargil E, eds, Handbook of Clinical Rheumatology. Ankara: Güven Kitabevi, 2003;504-16.
3. Braun J, Sieper J. Ankylosing spondylitis. Lancet. 2007;369(9570):1379-90.
4. Tanoue LT. Pulmonary involvement in collagen vascular disease. A review of the pulmonary manifestations of the Marfan syndrome, ankylosing spondylitis, Sjögren's syndrome and relapsing polychondritis. J Thorac Imaging. 1992;99:7(2):62-7.
5. Calin A, Garrett S, Whitelock H, Kennedy LG, O'Hea J, Mallorie P, Jenkinson T. A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index. J Rheumatol. 1994;21(12):2281-5.
6. Karatepe AG, Akkoc Y, Akar S, Kirazli Y, Akkoc N. The Turkish versions of the Bath Ankylosing Spondylitis and Dougados Functional Indices: reliability and validity. Rheumatol Int. 2005;25(8):612-8.
7. Akkoc Y, Karatepe AG, Akar S, Kirazli Y, Akkoc N. A Turkish version of the Bath Ankylosing Spondylitis Disease Activity Index: reliability and validity. Rheumatol Int. 2005;25(4):280-4.
8. Garrett S, Jenkinson T, Kennedy LG, Whitelock H, Gaisford P, Calin A. A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol. 1994;2112:2286-91.
9. Jenkinson TR, Mallorie PA, Whitelock HC, Kennedy LG, Garrett SL, Calin A. Defining spinal mobility in ankylosing spondylitis (AS). The Bath AS Metrology Index. J Rheumatol. 1994;21(9):1694-8.
10. Duruöz MT, Doward L, Turan Y Cerrahoglu L, Yurtkuran M, Calis M, Tas N, Ozgocmen S, Yoleri O, Durmaz B, Oncel S,Tuncer T, Sendur O, Birtane M, Tuzun F, Bingol U, Kirnap M, Celik Erturk G, Ardicoglu O, Memis A, Atamaz F, Kizil R, Kacar C, Gurer G, Uzunca K, Sari H. Translation and validation of the Turkish version of the Ankylosing Spondylitis Quality of Life (ASQOL) questionnaire. Rheumatol Int. 2013;33(11):2717-22.
11. Dincer U, Cakar E, Kıralp MZ, Bozkanat E, Kılac H, Dursun H. Pulmonary effects of ankylosing spondylitis and its impact on functionality and quality of life. Tohoku J Exp Med. 2007;212(4):423-30.
12. Şendur F, Karadağ F, Çildağ O, Başar A, Yıldırım T. The Evaluation of Pulmonary Findings of Ankylosing Spondylitis by Chest Radiography, Pulmonary Function Tests and High Resolution Computed Tomography. Tur Torax Der. 2001;2:50-2.
13. Sampaio-Barros PD, Cerqueira EM, Rezende SM, Maeda L, Conde RA, Zanardi VA, Bértolo MB, de Menezes Neto JR,Samara AM. Pulmonary involvement in ankylosing spondylitis. Clin Rheumatol. 2007;26(2):225-30.
14. Casserly IP, Fenlon HM, Breatnach E, Sant SM. Lung findings on high-resolution computed tomography in idiopathic ankylosing spondylitis-correlation with clinical findings, pulmonary function test in gand plain radiography. Br J Rheumatol. 1997;36(6):677-82.
15. Altin R, Ozdolap S, Savranlar A, Sarikaya S, Tor M, Kart L, Ozdemir H. Comparison of early and late pleuropulmonary findings of ankylosing spondylitis by high-resolution computed tomography and effects on patients daily life. Clin Rheumatol. 2005;24(1):22-8.
16. Fisher LR, Cawley MI, Holgate ST. Relation between chest expansion, pulmonary function, and exercise tolerance in patients with ankylosing spondylitis. Ann Rheum Dis. 1990;49(11):921-5.
17. Feltelius N, Hedenström H, Hillerdal G, Hallgren R. Pulmonary involvement in ankylosing spondylitis. Ann Rheum Dis. 1986;45(9):736-40.
18. Remy-Jardin M, Remy J, Boulenguez C, Sobaszek A, Edme JL, Furon D. Morphologic effects of cigarette smoking on airways and pulmonary parenchyma in healthy adult volunteers: CT evaluation and correlation with pulmonary function tests. Radiology. 1993;186(1):107-15.
19. Baser S, Cubukcu S, Ozkurt S, Sabir N, Akdag B, Diri E. Pulmonary involvement starts in early stage ankylosing spondylitis. Scand J Rheumatol. 2006;35(4):325-7.
20. Ozgul A, Peker F, Taskaynatan MA, Tan AK, Dinçer K, Kalyon TA. Effect of ankylosing spondylitis on health-related quality of life and different aspects of social life in young patients. Clin Rheumatol. 2006;25(2):168-74.
21. Ward MM, Weisman MH, Davis JC Jr, Reveille JD. Risk factors fo function allimitations in patients with long-standing ankylosing spondylitis. Arthritis Rheum. 2005;53(5):710-7.
22. El Maghraoui A, Chaouirs S, Abid A, Bezza A, Tabache F, Achemlal L, Abouzahir A, Ghafir D, Ohayon V, Archane MI. Lung finding on throcic high resolution computed tomography in patients with ankylosing spondylitis correlations with disease duration, clinica findings and pulmonary function testing. Clin Rheumatol. 2004;23(2):123-8.
23. Cerrahoğlu L, Unlu Z, Can M, Goktan C, Çelik P. Lumbar stifness but not thoracic radiographic changes relate to alteration of lung function tests in ankylosing spondylitis. Clin Rheumatol. 2002;21(4):275-9.
24. Uzunca K, Özdemir F. Evaluation of clinical activity and functiona limpairment in smokers with ankylosing spondylitis. Rheumatol Int. 2005;25(5):357-360.
25. Durmuş B, Altay Z, Baysal Ö, Ersoy Y, Hacıevliyagil SS, Baysal T, Aytemur ZA, Doğan E. Ankilozan spondilitli hastalarda yaş ve cinsiyete göre düzeltilmiş göğüs ekspansiyonunun klinik pratikte kullanımı. Turk J Phys Med Rehab. 2011;57(3):128-33.
26. Soyyigit S, Erk M, Güler N, Kilinç G. The value of SF-36 questionnaire for the measurement of life quality in chronic obstructive pulmonary disease. Tuberk Toraks. 2006;54(3):259-66.

APA	Büyükavcı R, Sağ S, OZKARAFAKİLİ M, KURAN K (2017). The effects of respiratory functions on disease activity, functionality, spinal mobility and quality of life in patients with ankylosing spondylitis. , 69 - 72.
Chicago	Büyükavcı Raikan,Sağ Sinem,OZKARAFAKİLİ Mufide Arzu,KURAN KADRİYE BANU The effects of respiratory functions on disease activity, functionality, spinal mobility and quality of life in patients with ankylosing spondylitis. (2017): 69 - 72.
MLA	Büyükavcı Raikan,Sağ Sinem,OZKARAFAKİLİ Mufide Arzu,KURAN KADRİYE BANU The effects of respiratory functions on disease activity, functionality, spinal mobility and quality of life in patients with ankylosing spondylitis. , 2017, ss.69 - 72.
AMA	Büyükavcı R,Sağ S,OZKARAFAKİLİ M,KURAN K The effects of respiratory functions on disease activity, functionality, spinal mobility and quality of life in patients with ankylosing spondylitis. . 2017; 69 - 72.
Vancouver	Büyükavcı R,Sağ S,OZKARAFAKİLİ M,KURAN K The effects of respiratory functions on disease activity, functionality, spinal mobility and quality of life in patients with ankylosing spondylitis. . 2017; 69 - 72.
IEEE	Büyükavcı R,Sağ S,OZKARAFAKİLİ M,KURAN K "The effects of respiratory functions on disease activity, functionality, spinal mobility and quality of life in patients with ankylosing spondylitis." , ss.69 - 72, 2017.
ISNAD	Büyükavcı, Raikan vd. "The effects of respiratory functions on disease activity, functionality, spinal mobility and quality of life in patients with ankylosing spondylitis". (2017), 69-72.

APA	Büyükavcı R, Sağ S, OZKARAFAKİLİ M, KURAN K (2017). The effects of respiratory functions on disease activity, functionality, spinal mobility and quality of life in patients with ankylosing spondylitis. Medicine Science, 6(1), 69 - 72.
Chicago	Büyükavcı Raikan,Sağ Sinem,OZKARAFAKİLİ Mufide Arzu,KURAN KADRİYE BANU The effects of respiratory functions on disease activity, functionality, spinal mobility and quality of life in patients with ankylosing spondylitis. Medicine Science 6, no.1 (2017): 69 - 72.
MLA	Büyükavcı Raikan,Sağ Sinem,OZKARAFAKİLİ Mufide Arzu,KURAN KADRİYE BANU The effects of respiratory functions on disease activity, functionality, spinal mobility and quality of life in patients with ankylosing spondylitis. Medicine Science, vol.6, no.1, 2017, ss.69 - 72.
AMA	Büyükavcı R,Sağ S,OZKARAFAKİLİ M,KURAN K The effects of respiratory functions on disease activity, functionality, spinal mobility and quality of life in patients with ankylosing spondylitis. Medicine Science. 2017; 6(1): 69 - 72.
Vancouver	Büyükavcı R,Sağ S,OZKARAFAKİLİ M,KURAN K The effects of respiratory functions on disease activity, functionality, spinal mobility and quality of life in patients with ankylosing spondylitis. Medicine Science. 2017; 6(1): 69 - 72.
IEEE	Büyükavcı R,Sağ S,OZKARAFAKİLİ M,KURAN K "The effects of respiratory functions on disease activity, functionality, spinal mobility and quality of life in patients with ankylosing spondylitis." Medicine Science, 6, ss.69 - 72, 2017.
ISNAD	Büyükavcı, Raikan vd. "The effects of respiratory functions on disease activity, functionality, spinal mobility and quality of life in patients with ankylosing spondylitis". Medicine Science 6/1 (2017), 69-72.